Hetero Drugs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24230TG1993PLC015582 Incorporated 06 April 1993 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹3,323.92 Cr
▲ 13.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹3.45 Cr
Issued & subscribed
Open charges
₹954.5 Cr
Satisfied ₹3,713.38 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
1,711
Latest available

About Hetero Drugs Limited

Data last updated: 07 February 2026

Hetero Drugs Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 06 April 1993, the company has been in operation for over 33 years.

Registered with ROC Hyderabad under CIN U24230AP1993PLC015582.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹3.45 Cr. Formerly known as Hetero Drugs Private Limited. It is led by directors including Adi Sesha Giri Jagarapu and Kalavathi Bandi.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹3,323.92 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 1,711 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹954.5 Cr and satisfied charges of ₹3,713.38 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hetero.com.

Company Details of Hetero Drugs Limited
CIN U24230TG1993PLC015582
Registration Number 015582
Incorporation Date 06 April 1993
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    #7 – 2 – A2 Industrial Estate, Sanathnagar, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, API Manufacturers
Company report
Hetero Drugs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Hetero Drugs Limited report

Financials, compliance, directors, charges, ownership and filings for Hetero Drugs Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Hetero Drugs Limited

Hetero Drugs Limited has one previous CIN (Corporate Identification Number): U24230AP1993PLC015582. The current CIN is U24230TG1993PLC015582, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230TG1993PLC015582 Current
U24230AP1993PLC015582 Previous

Business Activity of Hetero Drugs Limited

Hetero Drugs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Hetero Drugs Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Hetero Drugs Limited

Hetero Drugs Limited is currently managed by 7 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Adi Sesha Giri Jagarapu Director 23 Sep 2021 4 Years 9 Months Current
Kalavathi Bandi Director 01 Apr 2015 11 Years 3 Months Current
Venkatanarasa Reddy Attunuri Director 28 Jan 1999 27 Years 5 Months Current
Sambi Reddy Jonnala Whole-Time Director 01 Apr 2012 14 Years 3 Months Current
Parthasaradhi Reddy Bandi Director 01 Apr 2008 18 Years 3 Months Current
Bandi Vamsikrishna Director 10 Apr 2008 18 Years 3 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Hetero Drugs Limited FY 2025 filings available

Hetero Drugs Limited reported revenue of ₹3,323.92 Cr (up 13.00% YoY) for FY 2025.

Revenue · FY 2025
₹3,323.92 Cr ▲ 13.00%
Premium access

Ten-year financial statements for Hetero Drugs Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Hetero Drugs Limited

Open charges
₹954.5 Cr
Satisfied charges
₹3,713.38 Cr
Breakdown by lending institutions
Idbi Trusteeship Services Limited₹850.00 Cr
Industrial Development Bank of India₹81.00 Cr
Idbi Bank₹15.61 Cr
Others₹6.14 Cr
Bank of India₹1.76 Cr
Latest charge details
DateLenderAmountStatus
04 Sep 2025 Bank of India ₹10.5 Lakh Open
04 Sep 2025 Bank of India ₹14 Lakh Open
01 Sep 2025 Bank of India ₹8 Lakh Open
22 Aug 2025 Bank of India ₹14.88 Lakh Open
29 Jul 2025 Bank of India ₹9 Lakh Open

Total charge records: 72 View all charges

Employees and EPFO Compliance at Hetero Drugs Limited

View historical data on people associated with Hetero Drugs Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Hetero Drugs Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Hetero Drugs Limited

Premium access

GST registrations and filing compliance for Hetero Drugs Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Hetero Drugs Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Hetero Drugs Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hetero Drugs Limited

Premium access

MSME payment history for Hetero Drugs Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hetero Drugs Limited

Premium access

Corporate group structure for Hetero Drugs Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hetero Drugs Limited

Premium access

MCA filings and documents for Hetero Drugs Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Hetero Drugs Limited

Directors
13 Jan 2026
Kaza Sai Venkata Sharath Krishna was appointed as a Company Secretary on 13 Jan 2026 & has been associated with this company since 6 months 8 days.
Activity
29 Sep 2025
Hetero Drugs Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
04 Sep 2025
A charge with Bank Of India amounted to Rs. 0.11 Cr with Charge ID 101163367 was registered on 04 Sep 2025.
Charges
04 Sep 2025
A charge with Bank Of India amounted to Rs. 0.14 Cr with Charge ID 101163398 was registered on 04 Sep 2025.
Charges
01 Sep 2025
A charge with Bank Of India amounted to Rs. 0.08 Cr with Charge ID 101156685 was registered on 01 Sep 2025.
Charges
22 Aug 2025
A charge with Bank Of India amounted to Rs. 0.15 Cr with Charge ID 101156680 was registered on 22 Aug 2025.

Frequently Asked Questions about Hetero Drugs Limited

Hetero Drugs Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 06 April 1993 (33+ years old) and is registered under CIN U24230TG1993PLC015582. The company has 1,711 employees.

Hetero Drugs Limited reported revenue of ₹3,323.92 Cr for FY 2025 (up 13.00% YoY).

The current directors of Hetero Drugs Limited are:

The primary industry of Hetero Drugs Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Hetero Drugs Limited can be reached at the registered office: #7 – 2 – A2 Industrial Estate, Sanathnagar, Hyderabad, Telangana, India – 500018, or through the website hetero.com.

The authorised capital is ₹10 Cr, and the paid-up capital is ₹3.45 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available